Expanded Screening for HIV in the United States — An Analysis of Cost-Effectiveness
Top Cited Papers
Open Access
- 10 February 2005
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (6), 586-595
- https://doi.org/10.1056/nejmsa042088
Abstract
Although the Centers for Disease Control and Prevention (CDC) recommend routine HIV counseling, testing, and referral (HIVCTR) in settings with at least a 1 percent prevalence of HIV, roughly 280,000 Americans are unaware of their human immunodeficiency virus (HIV) infection. The effect of expanded screening for HIV is unknown in the era of effective antiretroviral therapy.Keywords
This publication has 20 references indexed in Scilit:
- Effective HIV Case Identification Through Routine HIV Screening at Urgent Care Centers in MassachusettsAmerican Journal of Public Health, 2005
- Evaluation of Initial CD4+T Cell Counts in Individuals with Newly Diagnosed Human Immunodeficiency Virus Infection, by Sex and Race, in Urban SettingsThe Journal of Infectious Diseases, 2002
- Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDSMedical Decision Making, 2002
- Are US Populations Appropriate for Trials of Human Immunodeficiency Virus Vaccine?American Journal of Epidemiology, 2001
- The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseNew England Journal of Medicine, 2001
- A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapyAIDS, 2000
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- The Care of HIV-Infected Adults in the United StatesNew England Journal of Medicine, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997